Guardant Health’s Shield Blood Test Now Covered for VA Community Care Beneficiaries (Business Wire)

Guardant Health’s Shield™ blood test for colorectal cancer (CRC) screening is now covered with no copay for U.S. veterans and eligible family members aged 45–84 under the VA Community Care Network. This marks the first coverage of the test for individuals younger than 65 and outside the Medicare population. Shield, FDA-approved in July 2024, is the first blood-based CRC screening test for average-risk individuals and can be prescribed by any provider. This expansion significantly increases access to early cancer detection for over 9 million VA beneficiaries.